Generation of Monoclonal Antibodies Targeting Advanced Glycation end Products: Phage display technology and microarray peptide and protein libraries for antibody development and validation

Medicine & Life Sciences

• Advanced Glycation End Products 87%
• Amines 15%
• Amino Acids 5%
• Antibodies 40%
• Antibody Formation 6%
• Antibody Specificity 8%
• Antigens 4%
• Arginine 6%
• Atherosclerosis 5%
• Autoantibodies 6%
• Bacteriophages 72%
• Chronic Disease 5%
• Clone Cells 5%
• Epitopes 25%
• Flow Cytometry 5%
• Glucose 4%
• Histones 6%
• Hyperglycemia 6%
• Immunohistochemistry 10%
• Immunoprecipitation 7%
• In Vitro Techniques 3%
• Inflammation 4%
• Libraries 12%
• Lysine 14%
• Microarray Analysis 7%
• Monoclonal Antibodies 53%
• N(6)-carboxymethyllysine 22%
• Neoplasms 2%
• Pancreatic Neoplasms 6%
• Peptide Library 100%
• Peptides 9%
• Printing 9%
• Prostatic Neoplasms 11%
• Proteins 26%
• Pyruvaldehyde 10%
• Rheumatoid Arthritis 12%
• Serum 3%
• Single-Chain Antibodies 9%
• Solid-Phase Synthesis Techniques 11%
• Spleen 5%
• Staining and Labeling 4%
• Sugars 7%
• Technology 47%